vitro
-
Stanford University Identifies Potential Drugs to Combat Hepatitis C
Stanford University School of Medicine scientists have discovered a novel class of compounds that in experiments in vitro, inhibit the replication of the virus that is responsible for hepatitis C. If these compounds prove effective in infected hu…
vitro | 28 January 2010
-
Advancell: Absorption and Oral Toxicity
Advancell develops, produces and commercializes cell-based in vitro models with predictive and regulatory value, to prove the efficacy, security and action mechanism of new molecules. Some of the in vitro models that are offered in the form …
vitro | 01 October 2009
-
Intelligent Sorbents: In-Vitro Diagnostic Applications
Choosing the right sorbent is vital in ensuring the integrity of packaged products.
vitro | 01 September 2009
-
Ortho Clinical Diagnostics Launches 24-Hour Remote Monitoring Center
Ortho Clinical Diagnostics has launched its remote monitoring center, a 24-7 central command center in the in vitro diagnostic industry that continuously tracks the condition of laboratory instrument performance. The center helps customers to identif…
vitro | 07 August 2009
-
Invitrogen Launches Online Resource for Cellular Technologies
Invitrogen has launched a comprehensive online resource for cell biology information and technology. The Cell Resource Center is a web portal that brings together educational resources and technologies for advancing cellular research. This web-based …
vitro | 17 July 2009
-
EU Launches Project to Improve In-Vitro Diagnostics
The European Union has launched a research project targeted at expanding the potentials and utility of in-vitro diagnostics. This is to be achieved through the creation of new standards for the collection, handling and processing of blood, tissue…
vitro | 16 January 2009
-
Invitrogen launches neuronal primary cell systems
Invitrogen Corp has announced the launch of its GIBCO Primary Rat Cortex and Hippocampus Neurons. These cells offer an alternative to freshly isolated neurons, which may exhibit significant variability from experiment to experiment. The cells…
vitro | 07 November 2008
-
Invitrogen shareholders approve merger with Applied Biosystems
Invitrogen Corp announced that its shareholders have voted to approve the company's proposed merger with Applied Biosystems at a special meeting of shareholders held on October 28, 2008. The preliminary tabulation indicates that more than 98% of t…
vitro | 04 November 2008
-
High quality microarray reagents
Invitrogen Corporation announced the launch of the SuperScript One-Cycle cDNA Synthesis Kit, designed to integrate seamlessly into the workflow of customers who are using Affymetrix One-Cycle Assays for their Affymetrix GeneChip microarray experiment…
vitro | 22 October 2008
-
New Kit Measures JAK2 Phosphorylation
Invitrogen’s JAK2 (pYpY1007â„1008) phosphoELISA kit is a complete ELISA assay to rapidly, efficiently and quantitatively detect phosphorylated JAK2. Phosphorylation, or the addition of phosphate groups, is essential to the activation of many enzym…
vitro | 01 October 2008
